Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inspiremd Inc 6303 WATERFORD DISTRICT DRIVE SUITE 215 MIAMI FL 33126 USA

www.inspiremd.com Employees: 86 P: 888-776-6804

Sector:

Medical

Description:

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.

Key Statistics

Overview:

Market Capitalization, $K 83,471
Enterprise Value, $K 64,551
Shares Outstanding, K 42,371
Annual Sales, $ 7,010 K
Annual Net Income, $ -32,010 K
Last Quarter Sales, $ 2,520 K
Last Quarter Net Income, $ -12,710 K
EBIT, $ -46,900 K
EBITDA, $ -46,620 K
60-Month Beta 0.70
% of Insider Shareholders 29.72%
% of Institutional Shareholders 44.78%
Float, K 29,778
% Float 70.28%
Short Interest 93
Short Float 0.22%
Short Volume Ratio 0.53

Growth:

1-Year Return -33.10%
3-Year Return 117.75%
5-Year Return -64.51%
5-Year Revenue Growth 88.44%
5-Year Earnings Growth 98.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 11/04/25
Next Earnings Date 03/11/26
Earnings Per Share ttm -0.84
EPS Growth vs. Prev Qtr 34.62%
EPS Growth vs. Prev Year -6.25%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 04/27/21

NSPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -124.20%
Return-on-Assets % -93.67%
Profit Margin % -456.63%
Debt/Equity 0.00
Price/Sales 11.79
Price/Cash Flow N/A
Price/Book 1.27
Book Value/Share 1.54
Interest Coverage -0.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar